# The HistoSonics Edison™ System for Treatment of Primary Solid Renal Tumors Using Histotripsy (#HOPE4KIDNEY)

> **NCT05820087** · NA · ACTIVE_NOT_RECRUITING · sponsor: **HistoSonics, Inc.** · enrollment: 67 (actual)

## Conditions studied

- Renal Cancer
- Tumor, Solid
- Kidney Cancer
- Tumor
- Tumor, Benign

## Interventions

- **DEVICE:** HistoSonics Edison System

## Key facts

- **NCT ID:** NCT05820087
- **Lead sponsor:** HistoSonics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-01-04
- **Primary completion:** 2025-09-04
- **Final completion:** 2030-07
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2025-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05820087

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05820087, "The HistoSonics Edison™ System for Treatment of Primary Solid Renal Tumors Using Histotripsy (#HOPE4KIDNEY)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05820087. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*